Catalent Biologics Completes $30 Million Project for Biopharmaceutical Development and Drug Product Manufacturing in Limoges, France

Excerpt Catalent announced the completion of a $30 million transformation project at its facility in Limoges, France, into a European center of excellence for biopharmaceutical development, drug product fill/finish services, and packaging. Article Summary The $30 million transformation project of Catalent site at Limoges, France caters to biopharmaceutical development, drug product fill/finish services, and packaging. With […]

Hilleman Laboratories Breaks Ground on Pilot cGMP Facility For Vaccine Development

Excerpt Hilleman Laboratories broke ground on a 30,000 square foot current Good Manufacturing Practices (cGMP) facility at 138 Depot Road as part of its official launch in Singapore. Article Summary Hilleman Laboratories, an organization with a mission to develop affordable vaccines and biologics against infectious disease, started a 30,000 square foot current Good Manufacturing Practices […]

Biogen Signs Agreement with Samsung Biologics to Sell Equity Stake in Their Biosimilar Joint Venture for up to $2.3 billion

Excerpt Biogen Inc. announced that Samsung Biologics and Biogen entered into an agreement where Biogen’s equity stake in the Samsung Bioepis joint venture will be acquired by Samsung Biologics for an aggregate consideration of up to USD $2.3 billion. Article Summary The companies will continue with their exclusive agreements, including for the commercialization of their […]

GenScript Sets Up State-Of-Art Manufacturing Facility in Singapore to Strengthen Manufacturing Capability

Excerpt GenScript Biotech Corporation, the world’s leading life science research tools and services provider, announced the opening of a more than a 30,000-square-feet facility for highly automated protein and gene preparation services in Singapore. Article Summary GenScript Biotech Corporation has announced the opening of a new site in Singapore that marks a significant expansion of […]

Moderna to Set Up New Subsidiary in Singapore, Malaysia, Taiwan and Hong Kong

Excerpt Moderna has announced plans to set up a new subsidiary in Singapore, along with three additional ones in Malaysia, Taiwan, and Hong Kong. The new subsidiaries will focus on mRNA platforms that rely on synthetic genes. These genes can be generated and manufactured in a shorter timeline and aim to produce big-scale vaccines more […]

WuXi STA Launches its First Parenteral Formulation Manufacturing Line

Excerpt WuXi STA, a subsidiary of WuXi AppTec, announced its first parenteral formulation manufacturing line at the Wuxi city site is now in operation. This fully automatic sterile manufacturing line has an annual capacity of 2 million units that operates in a full isolation system. Article Summary WuXi STA, new parenteral formulation manufacturing line at […]

Catalent Increases Specialized Packaging Capabilities at its Philadelphia Facility to Support Growing Biologic and Cell and Gene Therapy Market

Excerpt Catalent announced that it has increased cold chain packaging capabilities at its Philadelphia facility to support increased demand for the distribution of biologic drugs, and advanced cell and gene therapies. Article Summary Catalent has expanded the packaging area by around 20,000 square feet and includes the addition of seven new temperature-controlled processing suites, which […]

Lonza Launches bYlok Technology for the Discovery and Design of Bispecific Antibodies

Excerpt Lonza launches bYlok™ Technology – a new platform for the discovery and design of bispecific antibodies that can streamline future clinical manufacturing. Article Summary Bispecific antibodies (bsAbs) show promising results with higher potency and precision targeting. In addition, multiple binding sites can help reduce the development of subsequent clinical resistance. The biologics pipeline has […]

Prestige BioPharma Commences Construction of Innovative Discovery Center (IDC) in Busan, Korea

Excerpt Prestige BioPharma Limited a Singapore-based biopharmaceutical with operations in USA and South Korea, commences construction of Innovative Discovery Center (IDC) in Busan, South Korea. The construction of IDC is scheduled for completion by February 2023. Article Summary PBP holds a ceremony with Korean government officials and guests including Deputy Mayor of Busan City Mr. […]

Samsung Biologics to Construct New Manufacturing Facility for Next-Gen Vaccines and CGT

Excerpt Samsung Biologics is planning to construct a new manufacturing facility in Incheon, South Korea. This new facility will offer multi-product manufacturing, including cell and gene therapies and next-gen vaccines. Article Summary Samsung Biologics announced that it plans to start building a new facility, plant 5, this year at Songdo in Incheon, South Korea. The […]

Tower launches System for the Transport of Ultra Cold Temperature-critical Pharmaceuticals


Pharmaceutical thermal protection provider, Tower Cold Chain, launched its latest system, the KTM42D Tower Double Euro Pallet Ultra Cold, which is a fully reusable double-pallet temperature-controlled packaging container for the transportation and extended storage of products that require an internal temperature range of -80˚C to -60˚C. It is intended for the transportation of vaccines, life […]

German Cold Chain and Biopharma Logistics Firm Hit by Cyber Attack


Billion-dollar logistics firm Hellmann Worldwide Logistics reported a cyberattack this week that forced them to temporarily remove all connections to their central data center. The company said the shut down was having a “material impact” on their business operations.  The German company operates in 173 countries, running logistics for a range of air and sea […]